NCT07739277 Transverse vs. Longitudinal Serratus Anterior Plane Block in Breast Surgery
| NCT ID | NCT07739277 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Ankara Etlik City Hospital |
| Condition | Fascial Plane Block |
| Study Type | INTERVENTIONAL |
| Enrollment | 70 participants |
| Start Date | 2026-08-06 |
| Primary Completion | 2027-02-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 70 participants in total. It began in 2026-08-06 with a primary completion date of 2027-02-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this prospective, randomized controlled trial is to compare the analgesic efficacy of transverse versus longitudinal ultrasound probe orientations during Serratus Anterior Plane (SAP) block in patients undergoing breast surgery. The study hypothesizes that the longitudinal approach (probe parallel to the ribs) may provide better craniocaudal spread of the local anesthetic, thereby resulting in lower postoperative Visual Analog Scale (VAS) scores and reduced opioid consumption compared to the standard transverse approach.
Eligibility Criteria
Inclusion Criteria: * Patients aged between 18 and 65 years * American Society of Anesthesiologists (ASA) physical status I, II, or III * BMI between 18 - 30 kg/m2 * Patients scheduled for elective breast surgery * Ability to provide written informed consent Exclusion Criteria: * Known allergy to local anesthetics * Infection at the injection site * Severe coagulopathy or use of anticoagulants * Chronic opioid use or history of neuropathic pain
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07739277 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Fascial Plane Block. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07739277 currently recruiting?
Yes, NCT07739277 is actively recruiting participants. Contact the research team at ibrahimtpc78@gmail.com for enrollment information.
Where is the NCT07739277 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07739277 clinical trial?
NCT07739277 is sponsored by Ankara Etlik City Hospital. The trial plans to enroll 70 participants.